Author Archive for: Nikhil
About Nikhil Jain
This author has yet to write their bio.
Meanwhile lets just say that we are proud Nikhil Jain contributed a whooping 42 entries.
Entries by
Moving Sustainable Medicines Forward
February 28, 2020 by Nikhil JainPrescribed Grass
February 28, 2020 by Nikhil JainRisks of Cannabis Smoking
February 28, 2020 by Nikhil JainThe Science of Cannabis
February 28, 2020 by Nikhil JainCombining Cannabis With Other Herbs
Does cannabis have synergy with other plants? James Brent, DDS reviews the literature.
Tetrahydrocannabinol and cannabidiol oromucosal spray in resistant multiple sclerosis spasticity: consistency of response across subgroups from the SAVANT randomized clinical trial.
Authors: Sven G. Meuth, Thomas Henze, Ute Essner, Christiane Trompke, Carlos Vila Silván Published in International Journal of Neuroscience Abstract Objective: To determine whether differences in disability status, spasticity severity, and spasticity duration at treatment start in patients with resistant multiple sclerosis (MS) spasticity might influence response to add-on tetrahydrocannabinol:cannabidiol (THC:CBD) oromucosal spray (nabiximols) versus…
Factors Moderating the Association Between Cannabis Use and Psychosis Risk: A Systematic Review.
Authors: Sanne J. van der Steur, Albert Batalla, Matthijs G. Bossong Published in Brain Sciences 12 February 2020 Abstract Increasing evidence indicates a relationship between cannabis use and psychosis risk. Specific factors, such as determinants of cannabis use or the genetic profile of cannabis users, appear to moderate this association. The present systematic review…
Lifetime Average Cannabis Use in Relation to Hypertriglyceridemic Waist Phenotype in U.S. Adults: A Population-Based Cross-Sectional Study
Authors: Gerard Ngueta Published in Cannabis and Cannabinoid Research 11 February 2020 Abstract Background and Aims: With a growing number of states legalizing recreational or medical cannabis, prevalence of cannabis users is expected to markedly increase in the future. We aim to determine the association between lifetime cannabis use and the likelihood for hypertriglyceridemic…
Cannabinoid and Terpenoid Doses are Associated with Adult ADHD Status of Medical Cannabis Patients
An Israeli study identifies associations between the use of cannabinoids and terpenes for symptoms of attention deficit hyperactivity disorder (ADHD).
Response to UK Medical Cannabis Guidelines
Physicians from the UK give their critiques of recent medical cannabis regulations, noting the narrow window of qualifying conditions that do not include chronic pain, as well as advocating for the use of lower-cost, whole-plant flowers for patients.
The use of cannabis for Hyperemesis Gravidarum (HG).
Authors: Gideon Koren, Rana Cohen
Journal of Cannabis Research, 30 January 2020
—
Background: Hyperemesis Gravidarum (HG) responds only partially to standard antiemetic medications. Cannabis has been known to possess antiemetic effects and there are several medicinal cannabinoids used as anti -emetics for cancer chemotherapy. Its favorable use for HG has be…
Our Mission
The SCC provides continuing education for ourselves, patients, and colleagues about the medical use of cannabis and best practices in clinical care.
BECOME A MEMBER
Connect with healthcare professionals around the globe to get the most up-to-date medical cannabis information.